Ocular Therapeutix Cash Flow - Quarterly (NASDAQ:OCUL)

Add to My Stocks
$6.43 $0 (0%) OCUL stock closing price Sep 20, 2018 (Closing)

The Ocular Therapeutix cash flow statement helps investors understand how well the company is managing its cash flows. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about Ocular Therapeutix profits and Ocular Therapeutix debt. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Ocular Therapeutix stock analysis. Ocular Therapeutix generated $-24.71M cash from operating activities in till this quarter of 2018 Q2. Ocular Therapeutix has a positive cash and cash equivalents change of $15.3M.

View and download details of Ocular Therapeutix cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
-27.57M-13.76M-63.38M-50.28M-34.71M-16.02M-44.7M-31.88M-22.28M-10.84M
Depreciation Depletion Amortization Cash-Flow1.13M-1.64M1.11M--1.06M---
Net Increase (Decrease) in Assets Liabilities-2.11M-1.2M3.55M3.56M4.7M-0.63M2.07M--0.26M-0.1M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net3.85M1.92M7.72M5.51M3.66M1.81M7.55M4.32M2.92M1.38M
Net Cash from (used by) Operating Activities
-24.71M-12.47M-50.47M-40.09M-25.7M-14.57M-34M-26.38M-19.05M-9.25M
Increase (Decrease) in Prop Plant And Equipment-0.94M-0.38M-8.24M-7.68M-5.65M-1.65M-1.91M-1.23M-0.37M-0.12M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments--35.2M35.2M32.2M9.5M38.98M50.68M38.5M25M
Other Cash Inflow (Outflow) from Investment Activities-------1.5M-1.5M-1.5M-
Net Cash from (used by) Investment Activities
-0.94M-0.38M27.06M27.51M26.54M7.84M35.56M47.94M36.63M24.87M
Issuance (Purchase) of Equity Shares43.51M35.25M30.19M28.99M27.26M26.27M1.34M---
Issuance (Repayment) of Debt Securities-2.57M-1.02M2.4M2.4M2.4M2.4M----
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities---0.59M-0.59M-0.39M-0.19M-0.76M-0.38M-0.38M-0.19M
Net Cash from (used by) Financing Activities
40.94M34.22M32M30.8M29.27M28.47M--0.1M-0.18M-0.18M
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
15.3M21.37M8.6M18.22M30.11M21.74M2.15M21.45M17.38M15.42M
Cash & Equivalents at Beginning of Year43.15M32.93M30.78M37.39M17.5M23.85M5.33M---
Cash & Equivalents at Year End58.45M64.52M41.53M51.16M63.04M54.68M32.93M52.23M48.17M46.21M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Ocular Therapeutix stock price history and Ocular Therapeutix stock comparison chart inevitably reflect its cash flow situation.

  • Ocular Therapeutix had a Net Change in Cash and Cash Equivalents of $15.3M in the latest quarter 2018 Q2. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Ocular Therapeutix stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Ocular Therapeutix decreased its cash from operating activities to $-24.71M till 2018 Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: Ocular Therapeutix used $-0.94M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Ocular Therapeutix earned $40.94M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Ocular Therapeutix Cash Flow